ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences

Rhea-AI Summary

ImmunoGen, a leader in antibody-drug conjugates for cancer treatment, has announced key presentations at upcoming investor conferences. Management will present at the Guggenheim Healthcare Talks 2023 Oncology Conference on February 9 at 3:20 PM ET and at the SVB Securities Global Biopharma Conference on February 15 at 10:00 AM ET. These events will be webcast, with live access and replays available through the company's website. ImmunoGen is focused on developing novel therapies that improve cancer patients' outcomes, emphasizing their commitment to TARGET A BETTER NOW™.

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

• Guggenheim Healthcare Talks 2023 Oncology Conference

February 9 at 3:20pm ET

• SVB Securities Global Biopharma Conference

February 15 at 10:00am ET

A webcast of each presentation will be accessible through the “Investors and Media” section of the Company’s website, www.immunogen.com. Following the live webcast, a replay will be available at the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230201005203/en/

INVESTOR RELATIONS

ImmunoGen

Anabel Chan

781-895-0600

anabel.chan@immunogen.com

MEDIA

ImmunoGen

Courtney O'Konek

781-895-0600

courtney.okonek@immunogen.com

OR

FTI Consulting

Robert Stanislaro

212-850-5657

robert.stanislaro@fticonsulting.com

Source: ImmunoGen, Inc.

FAQ

What are the dates and times of ImmunoGen's upcoming presentations?

ImmunoGen will present at the Guggenheim Healthcare Talks 2023 Oncology Conference on February 9 at 3:20 PM ET and the SVB Securities Global Biopharma Conference on February 15 at 10:00 AM ET.

Where can I watch the ImmunoGen conference presentations?

The presentations by ImmunoGen will be webcast and can be accessed through the 'Investors and Media' section of their website at www.immunogen.com.

What is ImmunoGen's focus in cancer treatment?

ImmunoGen is dedicated to developing next-generation antibody-drug conjugates (ADCs) to improve treatment outcomes for cancer patients.

What is the significance of ImmunoGen's presentations at the conferences?

The presentations are crucial for discussing ImmunoGen's innovative cancer therapies and engaging with investors in the biopharmaceutical sector.

What is the purpose of ImmunoGen's commitment to TARGET A BETTER NOW™?

ImmunoGen aims to provide targeted therapies with enhanced anti-tumor activity and better tolerability for cancer patients, thus improving their quality of life.